iNova to acquire three ranges from Probiotec

31 August 2018 - Deborah Wilkes

Premium

iNova Pharmaceuticals has agreed to acquire a portfolio of products from Australian company Probiotec for AUD13.5 million (USD16.5 million) in cash.

Click tags below for more information on topics:

iNova

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: